International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatraemia: Extension to Studies CK-LX3401, 3405, and 3430

Trial Profile

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatraemia: Extension to Studies CK-LX3401, 3405, and 3430

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Lixivaptan (Primary)
  • Indications Hyponatraemia
  • Focus Adverse reactions; Registrational
  • Sponsors Cardiokine
  • Most Recent Events

    • 14 Aug 2014 New trial record
    • 20 Jun 2011
    • 24 Nov 2010
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top